| Paclitaxel | Approved Investigational Vet Approved | ABCB1 | 5243 |
upregulated | [Paclitaxel results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 mRNA | 7q21.12 | |
| Paclitaxel | Approved Investigational Vet Approved | ABCB1 | 5243 |
upregulated | Paclitaxel results in increased expression of ABCB1 mRNA | 7q21.12 | |
| Paclitaxel | Approved Investigational Vet Approved | ABCB6 | 10058 |
downregulated | Paclitaxel results in decreased expression of ABCB6 mRNA | 2q35 | |
| Paclitaxel | Approved Investigational Vet Approved | ABCC10 | 89845 |
upregulated | Paclitaxel results in increased expression of ABCC10 mRNA | 6p21.1 | |
| Paclitaxel | Approved Investigational Vet Approved | ABCC3 | 8714 |
upregulated | Paclitaxel results in increased expression of ABCC3 mRNA | 17q21.33 | |
| Paclitaxel | Approved Investigational Vet Approved | ABCC5 | 10057 |
upregulated | Paclitaxel results in increased expression of ABCC5 mRNA | 3q27.1 | |
| Paclitaxel | Approved Investigational Vet Approved | ABCG2 | 9429 |
downregulated | Paclitaxel results in decreased expression of ABCG2 mRNA | 4q22.1 | |
| Paclitaxel | Approved Investigational Vet Approved | ADCY6 | 112 |
downregulated | Paclitaxel results in decreased expression of ADCY6 mRNA | 12q13.12 | |
| Paclitaxel | Approved Investigational Vet Approved | AIFM1 | 9131 |
upregulated | Paclitaxel results in increased expression of AIFM1 mRNA | Xq26.1 | |
| Paclitaxel | Approved Investigational Vet Approved | APOD | 347 |
upregulated | Paclitaxel results in increased expression of APOD mRNA | 3q29 | |
| Paclitaxel | Approved Investigational Vet Approved | ASPM | 259266 |
upregulated | Paclitaxel results in increased expression of ASPM mRNA | 1q31.3 | |
| Paclitaxel | Approved Investigational Vet Approved | ATF5 | 22809 |
downregulated | Paclitaxel results in decreased expression of ATF5 mRNA | 19q13.33 | |
| Paclitaxel | Approved Investigational Vet Approved | ATP7A | 538 |
upregulated | Paclitaxel results in increased expression of ATP7A mRNA | Xq21.1 | |
| Paclitaxel | Approved Investigational Vet Approved | AURKA | 6790 |
upregulated | Paclitaxel results in increased expression of AURKA mRNA | 20q13.2 | |
| Paclitaxel | Approved Investigational Vet Approved | BAD | 572 |
upregulated | Paclitaxel results in increased expression of BAD mRNA | 11q13.1 | |
| Paclitaxel | Approved Investigational Vet Approved | BAK1 | 578 |
upregulated | Paclitaxel results in increased expression of BAK1 mRNA | 6p21.31 | |
| Paclitaxel | Approved Investigational Vet Approved | BAX | 581 |
upregulated | Paclitaxel results in increased expression of BAX mRNA | 19q13.33 | |
| Paclitaxel | Approved Investigational Vet Approved | BAX | 581 |
upregulated | [Paclitaxel results in increased expression of TP53 protein] which results in increased expression of BAX mRNA | 19q13.33 | |
| Paclitaxel | Approved Investigational Vet Approved | BBC3 | 27113 |
upregulated | Paclitaxel results in increased expression of BBC3 mRNA | 19q13.32 | |
| Paclitaxel | Approved Investigational Vet Approved | BCL2 | 596 |
downregulated | Paclitaxel results in decreased expression of BCL2 mRNA | 18q21.33 | |
| Paclitaxel | Approved Investigational Vet Approved | BCL2 | 596 |
upregulated | Paclitaxel results in increased expression of BCL2 mRNA | 18q21.33 | |
| Paclitaxel | Approved Investigational Vet Approved | BCL2L1 | 598 |
downregulated | Paclitaxel results in decreased expression of BCL2L1 mRNA | 20q11.21 | |
| Paclitaxel | Approved Investigational Vet Approved | BCL2L1 | 598 |
upregulated | Paclitaxel results in increased expression of BCL2L1 mRNA | 20q11.21 | |
| Paclitaxel | Approved Investigational Vet Approved | BIN1 | 274 |
upregulated | Paclitaxel results in increased expression of BIN1 mRNA | 2q14.3 | |
| Paclitaxel | Approved Investigational Vet Approved | BIRC5 | 332 |
downregulated | Paclitaxel results in decreased expression of BIRC5 mRNA | 17q25.3 | |